DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/w886vm/biotechnology_biot) has announced the addition of the "Biotechnology Biotech Finances" subscription to their offering.

The premier European weekly newsletter dedicated to all the financial aspects Biotechnology Biotech Finances has more than 22,000 weekly readers worldwide who use it as their invaluable first point of reference because it:

- Provides up-to-date, pertinent information delivered by experts, investigators and journalists who talk directly to the people who matter;

- Offers efficient networking with professionals through our search engine;

- Helps identify and target potential investors and partners;

- Facilitates exclusive business opportunities, collaboration offers, recruitment, finding investors, acquiring licensing rights, finding equipment and premises, all of which is reported directly by industry leaders in the interviews featured in the newsletter.

Why is Biotech Finances different?

Biotech Finances does not recycle news stories that have already been published elsewhere. A team of specialists actually talk to key players in the field, such as CEOs of leading companies, politicians and regulators. As a result, you'll find news in Biotech Finances that you won't find elsewhere.

In addition, Biotech Finances' tables of financial transactions in the biotechnology field provide early notification of key M&A activity in the sector. Ultimately, Biotech Finances provides the information your business needs to succeed in the dynamic field of biotechnology.

Here is the original post:
Research and Markets: Biotechnology Biotech Finances